PvP Biologics, Inc.   Report issue

For profit Phase 1
Founded: San Diego CA United States (2016)
Status: Acquired by Takeda (2020)

Organization Overview

First Clinical Trial
2018
NCT03594331
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

PvP Biologics, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

pvp001 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Celiac Disease (Phase 1)

Digestive System Diseases (Phase 1)

Gastrointestinal Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1